CLASS II Drug recall · Reported 3 Dec 2014 · FDA Enforcement Report

Potassium Chloride in 5% Dextrose recalled by Hospira

Hospira is recalling Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP container, distributed nationwide in the US. The recall was initiated on 14 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 34-017-JT; Exp. 10/15 Lot # 35-100-JT; Exp. 11/15
Quantity recalled836,460 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0278-2015
FDA event ID
69494
Recalling firm
Hospira, Lake Forest, IL
Classification
Class II
Status
Terminated
Recall initiated
14 Oct 2014
FDA classified
25 Nov 2014
Reported
3 Dec 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

14 Oct 2014Recall initiated by company
25 Nov 2014Classified by FDA+42 days
3 Dec 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7902-09.

Where it was distributed

Nationwide, Puerto Rico, and U.S. Virgin Islands.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Which lots are affected?

Lot # 34-017-JT; Exp. 10/15 Lot # 35-100-JT; Exp. 11/15

Where was it sold?

Nationwide, Puerto Rico, and U.S. Virgin Islands.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

10 other products · FDA event 69494

This product is part of a recall event; the main page for the event is 5% Dextrose and 0.9% Sodium Chloride Injection, USP container recalled.

More recalls from Hospira

All 225

Other Potassium Chloride recalls

All 23
ReportedClassRecallCompanyReasonWhere
DrugCLASS IPotassium Chloride Inj., 20 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 20 mEq total in flexible container recalledPotassium ChlorideICU MedicalLabeling ErrorsNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total recalled by ICU MedicalPotassium ChlorideICU MedicalOtherNationwide
DrugCLASS IIPotassium Chloride Extended-Release Tablets, USP, 10 mEq recalledPotassium ChlorideThe Harvard Drug GroupPotency & AssayNationwide